Back to CTNM
GOLDMAN SACHS GROUP INC → CTNM
GOLDMAN SACHS GROUP INC CTNM Position History
Contineum Therapeutics, Inc. • Healthcare
Quarters held
9
Latest value
$805K
Q2 2026
Peak value
$7.3M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $193K |
| Q2 2025 | $49K |
| Q3 2025 | $195K |
| Q3 2025 | $159K |
| Q4 2025 | $1.2M |
| Q4 2025 | $1.2M |
| Q1 2026 | $4M |
| Q2 2026 | $7.3M |
| Q2 2026 | $805K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $805K | 49.1K | — | — |
| Q2 2026 | $7.3M | 448.1K | — | — |
| Q1 2026 | $4M | 307.1K | — | — |
| Q4 2025 | $1.2M | 105.6K | — | — |
| Q4 2025 | $1.2M | 105.6K | — | — |
| Q3 2025 | $159K | 13.5K | — | — |
| Q3 2025 | $195K | 16.6K | — | — |
| Q2 2025 | $49K | 12.3K | — | — |
| Q2 2025 | $193K | 48.6K | — | — |
Other funds holding CTNM
$32.4M
$26.6M
$25.8M
$23.3M
$23.3M
$22.6M
$22.6M